Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AVH0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 14 |
GO:0006396 | RNA processing | 6 | 14 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0016070 | RNA metabolic process | 5 | 14 |
GO:0031123 | RNA 3'-end processing | 7 | 14 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 14 |
GO:0043170 | macromolecule metabolic process | 3 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 14 |
GO:0046483 | heterocycle metabolic process | 3 | 14 |
GO:0071076 | RNA 3' uridylation | 8 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:0090304 | nucleic acid metabolic process | 4 | 14 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 14 |
GO:0006378 | mRNA polyadenylation | 7 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0031124 | mRNA 3'-end processing | 8 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 14 |
GO:0016779 | nucleotidyltransferase activity | 4 | 14 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 14 |
GO:0070569 | uridylyltransferase activity | 5 | 14 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 14 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 14 |
GO:0004652 | obsolete polynucleotide adenylyltransferase activity | 6 | 4 |
GO:0005488 | binding | 1 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0070566 | adenylyltransferase activity | 5 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.424 |
CLV_MEL_PAP_1 | 7 | 13 | PF00089 | 0.401 |
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.705 |
CLV_NRD_NRD_1 | 155 | 157 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.371 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.404 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.731 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.364 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.421 |
DEG_APCC_DBOX_1 | 188 | 196 | PF00400 | 0.439 |
DEG_APCC_DBOX_1 | 48 | 56 | PF00400 | 0.421 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.479 |
DOC_CKS1_1 | 291 | 296 | PF01111 | 0.379 |
DOC_CYCLIN_yCln2_LP_2 | 341 | 347 | PF00134 | 0.393 |
DOC_MAPK_gen_1 | 131 | 139 | PF00069 | 0.456 |
DOC_MAPK_gen_1 | 143 | 151 | PF00069 | 0.302 |
DOC_MAPK_gen_1 | 372 | 378 | PF00069 | 0.435 |
DOC_MAPK_MEF2A_6 | 164 | 171 | PF00069 | 0.362 |
DOC_MAPK_NFAT4_5 | 164 | 172 | PF00069 | 0.385 |
DOC_PP1_RVXF_1 | 350 | 357 | PF00149 | 0.342 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.592 |
DOC_USP7_MATH_1 | 248 | 252 | PF00917 | 0.458 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.482 |
DOC_USP7_UBL2_3 | 160 | 164 | PF12436 | 0.283 |
DOC_USP7_UBL2_3 | 66 | 70 | PF12436 | 0.535 |
DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.286 |
DOC_WW_Pin1_4 | 212 | 217 | PF00397 | 0.336 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.373 |
DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.635 |
LIG_14-3-3_CanoR_1 | 10 | 15 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 131 | 141 | PF00244 | 0.443 |
LIG_14-3-3_CanoR_1 | 232 | 238 | PF00244 | 0.485 |
LIG_14-3-3_CanoR_1 | 311 | 318 | PF00244 | 0.384 |
LIG_14-3-3_CanoR_1 | 35 | 42 | PF00244 | 0.398 |
LIG_Actin_WH2_2 | 162 | 177 | PF00022 | 0.393 |
LIG_AP2alpha_2 | 343 | 345 | PF02296 | 0.353 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.466 |
LIG_BRCT_BRCA1_1 | 161 | 165 | PF00533 | 0.469 |
LIG_BRCT_BRCA1_1 | 352 | 356 | PF00533 | 0.345 |
LIG_CtBP_PxDLS_1 | 359 | 365 | PF00389 | 0.187 |
LIG_deltaCOP1_diTrp_1 | 316 | 321 | PF00928 | 0.366 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.311 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.461 |
LIG_FHA_2 | 87 | 93 | PF00498 | 0.406 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.433 |
LIG_LIR_Gen_1 | 220 | 227 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 283 | 291 | PF02991 | 0.288 |
LIG_LIR_Gen_1 | 298 | 306 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 316 | 325 | PF02991 | 0.437 |
LIG_LIR_Gen_1 | 329 | 339 | PF02991 | 0.247 |
LIG_LIR_Gen_1 | 377 | 382 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 220 | 226 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 283 | 288 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 298 | 302 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 316 | 321 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 329 | 334 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 377 | 382 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 98 | 102 | PF02991 | 0.357 |
LIG_NRBOX | 51 | 57 | PF00104 | 0.425 |
LIG_Pex14_1 | 213 | 217 | PF04695 | 0.315 |
LIG_REV1ctd_RIR_1 | 354 | 362 | PF16727 | 0.360 |
LIG_SH2_CRK | 291 | 295 | PF00017 | 0.467 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.384 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.407 |
LIG_SH2_STAP1 | 217 | 221 | PF00017 | 0.295 |
LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.452 |
LIG_SH3_3 | 341 | 347 | PF00018 | 0.365 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.405 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.416 |
LIG_SUMO_SIM_anti_2 | 276 | 281 | PF11976 | 0.496 |
LIG_SUMO_SIM_anti_2 | 337 | 343 | PF11976 | 0.344 |
LIG_SUMO_SIM_par_1 | 302 | 308 | PF11976 | 0.299 |
LIG_SUMO_SIM_par_1 | 337 | 343 | PF11976 | 0.331 |
LIG_TRAF2_1 | 271 | 274 | PF00917 | 0.362 |
LIG_TRAF2_1 | 65 | 68 | PF00917 | 0.481 |
LIG_TRAF2_2 | 271 | 276 | PF00917 | 0.394 |
LIG_TYR_ITIM | 77 | 82 | PF00017 | 0.463 |
LIG_UBA3_1 | 126 | 132 | PF00899 | 0.413 |
LIG_UBA3_1 | 221 | 228 | PF00899 | 0.349 |
MOD_CDK_SPK_2 | 155 | 160 | PF00069 | 0.286 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.431 |
MOD_CK1_1 | 98 | 104 | PF00069 | 0.349 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.478 |
MOD_CK2_1 | 155 | 161 | PF00069 | 0.508 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.491 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.390 |
MOD_CK2_1 | 275 | 281 | PF00069 | 0.272 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.360 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.432 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.599 |
MOD_GlcNHglycan | 31 | 35 | PF01048 | 0.532 |
MOD_GlcNHglycan | 367 | 370 | PF01048 | 0.454 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.377 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.369 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.425 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.427 |
MOD_GSK3_1 | 346 | 353 | PF00069 | 0.449 |
MOD_GSK3_1 | 374 | 381 | PF00069 | 0.371 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.485 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.387 |
MOD_N-GLC_2 | 4 | 6 | PF02516 | 0.392 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.332 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.338 |
MOD_NEK2_1 | 227 | 232 | PF00069 | 0.358 |
MOD_PIKK_1 | 240 | 246 | PF00454 | 0.442 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.437 |
MOD_PKA_2 | 106 | 112 | PF00069 | 0.621 |
MOD_PKA_2 | 310 | 316 | PF00069 | 0.480 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.464 |
MOD_PKB_1 | 309 | 317 | PF00069 | 0.397 |
MOD_Plk_1 | 165 | 171 | PF00069 | 0.283 |
MOD_Plk_1 | 258 | 264 | PF00069 | 0.474 |
MOD_Plk_1 | 275 | 281 | PF00069 | 0.411 |
MOD_Plk_4 | 174 | 180 | PF00069 | 0.329 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.269 |
MOD_Plk_4 | 265 | 271 | PF00069 | 0.377 |
MOD_Plk_4 | 374 | 380 | PF00069 | 0.425 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.391 |
MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.288 |
MOD_ProDKin_1 | 212 | 218 | PF00069 | 0.332 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.373 |
MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.615 |
MOD_SUMO_for_1 | 371 | 374 | PF00179 | 0.347 |
MOD_SUMO_for_1 | 65 | 68 | PF00179 | 0.518 |
MOD_SUMO_rev_2 | 62 | 72 | PF00179 | 0.581 |
TRG_DiLeu_BaEn_1 | 329 | 334 | PF01217 | 0.423 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.270 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.432 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.731 |
TRG_ER_diArg_1 | 145 | 148 | PF00400 | 0.400 |
TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.342 |
TRG_ER_diArg_1 | 306 | 309 | PF00400 | 0.418 |
TRG_ER_diArg_1 | 49 | 51 | PF00400 | 0.457 |
TRG_Pf-PMV_PEXEL_1 | 35 | 39 | PF00026 | 0.451 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA71 | Leptomonas seymouri | 63% | 100% |
A0A0S4IUE3 | Bodo saltans | 34% | 85% |
A0A0S4IXY7 | Bodo saltans | 21% | 100% |
A0A1X0NI50 | Trypanosomatidae | 45% | 100% |
A0A1X0NT04 | Trypanosomatidae | 25% | 100% |
A0A3R7LQY4 | Trypanosoma rangeli | 26% | 100% |
A0A3R7M9K0 | Trypanosoma rangeli | 45% | 100% |
A0A3S7WWT5 | Leishmania donovani | 94% | 100% |
A4HC38 | Leishmania braziliensis | 82% | 100% |
A4HZI0 | Leishmania infantum | 94% | 100% |
D0A0Y4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
O13833 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 94% |
Q4QC09 | Leishmania major | 90% | 100% |
V5B3T6 | Trypanosoma cruzi | 26% | 100% |